Table 4 Treatment uptake as defined by percentage of eligible study participants who received treatment, with eligibility for treatment determined by hepatitis C RNA-positive status and other criteria
Author, year | % treated (# treated/# of treatment candidates) | SVR (%) (# with sustained viral response/# treated) |
|---|---|---|
Defossez et al, 2008 | 24% (13/55)1 | NA |
Grando-Lemaire et al, 2002 | 58% (27/47) | Intent-to-treat: 19% (5/27) As-treated: 33% (5/15) |
Jack et al, 2009 | 70% (30/43) | Intent-to-treat: 62% (13/21) As-treated: 77% (13/17) |
Jowett et al, 2000 | 50% (50/100) | Intent-to-treat: 36% (18/50) |
Kristensen et al, 2009 | 33% (6/9) | NA |
Lindenburg et al, 2011 | 76% (58/76) | Intent-to-treat: 65% (37/57) As-treated: 77% (37/48) |